• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rationales for a pharmacologically optimized treatment of acute nonlymphocytic leukemia with cytosine arabinoside.

作者信息

Heinemann V, Jehn U

机构信息

Department of Internal Medicine, Hematology/Oncology, Klinikum Grosshadern, University of Munich, F.R.G.

出版信息

Leukemia. 1990 Nov;4(11):790-6.

PMID:2232893
Abstract
摘要

相似文献

1
Rationales for a pharmacologically optimized treatment of acute nonlymphocytic leukemia with cytosine arabinoside.
Leukemia. 1990 Nov;4(11):790-6.
2
Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy.
Clin Sci (Lond). 1981 Feb;60(2):191-8. doi: 10.1042/cs0600191.
3
Multiple determinants of antimetabolite action in humans.人类抗代谢物作用的多种决定因素。
Bull Cancer. 1979;66(1):93-6.
4
Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C).
Semin Oncol. 1985 Jun;12(2 Suppl 3):1-8.
5
Pharmacologic studies of low-dose and high-dose continuous infusion cytosine arabinoside.低剂量和高剂量持续输注阿糖胞苷的药理学研究。
Semin Oncol. 1987 Jun;14(2 Suppl 1):149-58.
6
Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson Hospital.在MD安德森医院开展的高剂量阿糖胞苷临床研究的进展
Semin Oncol. 1985 Jun;12(2 Suppl 3):98-104.
7
Prediction of therapeutic response in acute myelocytic leukemia.急性髓细胞白血病治疗反应的预测
Haematol Blood Transfus. 1979;23:93-8. doi: 10.1007/978-3-642-67057-2_11.
8
Biochemical and cellular pharmacology of cytosine arabinoside.
Semin Oncol. 1985 Jun;12(2 Suppl 3):34-48.
9
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.高剂量1-β-D-阿拉伯呋喃糖基胞嘧啶治疗期间白血病细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸积累的饱和度
Cancer Res. 1987 Jun 1;47(11):3005-11.
10
Cellular pharmacology and optimal therapeutic concentrations of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic blasts during treatment of refractory leukemia with high-dose 1-beta-D-arabinofuranosylcytosine.大剂量1-β-D-阿拉伯呋喃糖基胞嘧啶治疗难治性白血病期间白血病母细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸的细胞药理学及最佳治疗浓度
Scand J Haematol Suppl. 1986;44:51-9. doi: 10.1111/j.1600-0609.1986.tb01590.x.

引用本文的文献

1
SAMHD1 protects cancer cells from various nucleoside-based antimetabolites.SAMHD1保护癌细胞免受各种基于核苷的抗代谢物的影响。
Cell Cycle. 2017 Jun 3;16(11):1029-1038. doi: 10.1080/15384101.2017.1314407. Epub 2017 Apr 24.
2
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.利用 Vpx 蛋白靶向 SAMHD1 以改善血液系统恶性肿瘤的阿糖胞苷治疗。
Nat Med. 2017 Feb;23(2):256-263. doi: 10.1038/nm.4265. Epub 2017 Jan 9.
3
Individualised cancer chemotherapy: strategies and performance of prospective studies on therapeutic drug monitoring with dose adaptation: a review.
个体化癌症化疗：剂量调整的治疗药物监测前瞻性研究的策略与成效：一项综述
Clin Pharmacokinet. 2005;44(2):147-73. doi: 10.2165/00003088-200544020-00002.
4
Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine.中剂量阿糖胞苷与安吖啶治疗难治性急性白血病的Ⅱ期研究
Ann Hematol. 1993 Mar;66(3):131-4. doi: 10.1007/BF01697622.
5
Pharmacokinetic optimisation of anticancer therapy.抗癌治疗的药代动力学优化
Clin Pharmacokinet. 1991 Sep;21(3):213-31. doi: 10.2165/00003088-199121030-00005.
6
In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia.
Med Oncol Tumor Pharmacother. 1992;9(2):65-74. doi: 10.1007/BF02989656.